THE RED HOUSE GROUP — All Prescriptions & Medications — Page 2
Practice Code: E82085 | RADLETT, WD7 7JQ
Showing results 51-100 of 700
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Candesartan cilexetil | 1,208 | 70.4K | £3.3K | +1.8% vs avg |
| Alendronic acid | 1,206 | 8,004 | £2.2K | +60.8% ▲ |
| Venlafaxine | 1,173 | 49.1K | £11.6K | +38.8% ▲ |
| Budesonide | 1,158 | 2,559 | £52.2K | +113.7% ▲ |
| Gliclazide | 1,147 | 89.7K | £3.5K | +34.8% ▲ |
| Other emollient preparations | 1,132 | 615.6K | £7.5K | +88.5% ▲ |
| Ezetimibe | 1,104 | 54.6K | £9.5K | +55.2% ▲ |
| Quetiapine | 1,008 | 36.5K | £11.0K | +61.9% ▲ |
| Mometasone furoate | 1,000 | 1,221 | £9.5K | +149.1% ▲ |
| Carbocisteine | 964 | 100.1K | £2.6K | +80.6% ▲ |
| Gabapentin | 941 | 111.7K | £3.5K | -5.8% ▼ |
| Donepezil hydrochloride | 937 | 15.7K | £1.0K | +203.7% ▲ |
| Flucloxacillin sodium | 925 | 39.1K | £2.2K | +105.7% ▲ |
| Naproxen | 921 | 51.4K | £2.8K | -6.7% ▼ |
| Spironolactone | 914 | 28.1K | £2.5K | +69.5% ▲ |
| Escitalopram | 914 | 45.4K | £3.1K | +221.1% ▲ |
| Isosorbide mononitrate | 898 | 29.1K | £4.9K | +35.9% ▲ |
| Estradiol with progestogen | 894 | 39.7K | £24.7K | +162.3% ▲ |
| Estradiol | 832 | 22.9K | £12.6K | +208.4% ▲ |
| Doxycycline hyclate | 831 | 14.5K | £1.3K | +62.1% ▲ |
| 820 | 13.6K | £8.7K | +23.4% ▲ | |
| Felodipine | 814 | 45.9K | £7.2K | +37.1% ▲ |
| Diazepam | 809 | 41.3K | £2.3K | +62.4% ▲ |
| Hydrocortisone | 798 | 22.3K | £5.1K | +78.0% ▲ |
| Linagliptin | 795 | 16.2K | £18.4K | +94.1% ▲ |
| Betamethasone valerate | 794 | 63.0K | £3.8K | +106.2% ▲ |
| Combined ethinylestradiol 30mcg | 788 | 73.3K | £6.5K | +183.7% ▲ |
| Esomeprazole | 779 | 43.0K | £5.5K | +92.5% ▲ |
| Mirabegron | 776 | 29.2K | £26.9K | +93.2% ▲ |
| Fluticasone propionate (Inhalation) | 774 | 1,317 | £30.5K | +100.0% ▲ |
| Ferrous fumarate | 772 | 52.9K | £1.8K | +6.5% ▲ |
| 757 | 1,920 | £64.9K | +38.9% ▲ | |
| Rivaroxaban | 741 | 34.9K | £25.2K | +21.1% ▲ |
| Co-careldopa (Carbidopa/levodopa) | 739 | 92.4K | £7.5K | +227.0% ▲ |
| Glucose blood testing reagents | 736 | 81.0K | £13.5K | -6.7% ▼ |
| Cyanocobalamin | 735 | 35.6K | £4.1K | +108.2% ▲ |
| 717 | 107.8K | £4.8K | +51.1% ▲ | |
| Promethazine hydrochloride | 716 | 28.8K | £4.2K | +100.3% ▲ |
| Alginic acid compound preparations | 702 | 353.8K | £6.0K | +19.8% ▲ |
| Bumetanide | 676 | 20.1K | £2.0K | +148.1% ▲ |
| Diltiazem hydrochloride | 669 | 37.7K | £7.9K | +117.8% ▲ |
| Digoxin | 668 | 15.8K | £1.2K | +76.5% ▲ |
| Insulin aspart | 644 | 4,585 | £30.4K | +69.1% ▲ |
| Bendroflumethiazide | 632 | 38.9K | £633 | -18.3% ▼ |
| Diclofenac diethyl | 625 | 67.6K | £3.5K | +76.0% ▲ |
| Sitagliptin | 622 | 26.2K | £2.0K | +59.5% ▲ |
| Montelukast | 599 | 20.4K | £1.1K | -12.5% ▼ |
| Methotrexate | 599 | 16.4K | £8.7K | +84.0% ▲ |
| Desogestrel | 581 | 63.6K | £2.7K | +46.6% ▲ |
| Mesalazine (Systemic) | 579 | 108.2K | £53.4K | +141.7% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.